References
- Theise ND , SaxenaR, PortmannBCet al. The canals of Hering and hepatic stem cells in humans. Hepatology30, 1425–1433 (1999).
- Yoon SM , GerasimidouD, KuwaharaRet al. Epithelial cell adhesion molecule (EpCAM) marks hepatocytes newly derived from stem/progenitor cells in humans. Hepatology53, 964–973 (2011).
- Lin WR , LimSN, McDonaldSAet al. The histogenesis of regenerative nodules in human liver cirrhosis. Hepatology51, 1017–1026 (2011).
- Wang B , ZhaoL, FishMet al. Self-renewing diploid Axin2(+) cells fuelhomeostatic renewal of the liver. Nature524, 180–185 (2015).
- Theise ND , DolléL, KuwaharaR. Low hepatocyte repopulation from stem cells: a matter of hepato-biliary linkage not massive production. Gastroenterology145, 253–254 (2013).
- Kuwahara R , KofmanAV, LandisCS, SwensonES, BarendswaardE, TheiseND. The hepatic stem cell niche: identification by label retaining cell assay. Hepatology47, 1994–2002 (2008).
- Holczbauer A , FactorVM, AndersenJBet al. Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types. Gastroenterology145, 221–231 (2013).
- Zucman-Rossi J , NaultJC, ZenderL. Primary liver carcinomas can originate from different cell types: a new level of complexity in hepatocarcinogenesis. Gastroenterology145, 53–55 (2013).
- Raggi C , FactorVM, SeoDet al. Epigenetic reprogramming modulates malignant properties of human liver cancer. Hepatology59, 2251–2262 (2014).
- Oikawa T , WaulthierE, DinhTAet al. Model of fibrolamellar hepatocellular carcinomas reveals striking enrichment in cancer stem cells. Nat. Commun.6, 8070 (2015).
- Michalopoulos GK , GrompeM, TheiseND. Assessing the potential of induced liver regeneration. Nat. Med.19, 1096–1097 (2013).
- Brunt EM , SempouxC, ParadisV, TheiseND. Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress. Hepat. Oncol.2(3), 255–273 (2015).
- International Consensus Group for Hepatocellular Neoplasia (ICGHN) Group . Pathologic diagnosis of early hepatocellular carcinoma; a report of the International Consensus Group for Hepatocellular Neoplasia. Hepatology49, 658–664 (2009).